Диссертация (1140778), страница 12
Текст из файла (страница 12)
«SCORE project group. Estimation of ten-yearrisk of fatal cardiovascular disease in Europe: the SCORE project.». Eur Heart J 24(11): 987-100310169. Morisky D. E., Green L. W., Levine D. M. Concurrent and predictive validity ofa self-reported measure of medication adherence. Med Care 1986; 24(1): 67-74.70 Kalashnikova MF, Bondarev IB, Lihodey NV.
Adherence to treatment with type2 diabetes: the definition, the modern methods of assessing patient treatment.Lechashchiy Vrach 2015; 3: 27-33. In Russian (Калашникова М.Ф., БондареваИ.Б., Лиходей Н.В. Приверженность лечению при сахарном диабете 2-го типа:определение понятия, современные методы оценки пациентами проводимого лечения. Лечащий Врач 2015; 3: 27-33).71 Lukina YuV, Ginzburg ML, Smirnov VP et al. Adherence to treatment, priorhospitalization for patients with acute coronary syndrome. Klinitsist 2012; 2: 45-53.In Russian (Лукина Ю.В., Гинзбург М.Л., Смирнов В.П. и др. Приверженностьлечению, предшествующему госпитализации, у пациентов с острымкоронарным синдромом. Клиницист 2012; 2: 45-53).72.
Aroney CN, Dunlevie HL, Bett JH. Use of an accelerated chest pain assessmentrotocol in patients at intermediate risk of adverse cardiac events. Med. J. Aust. 2003;178 (8): 370-37473. Parsonage WA, Cullen L, Younger JF. The approach to patients with possiblecardiac chest pain. Med. J. Aust. 2013; 199 (1): 30-34.
DOI:10.5694/mja12.1117110274. Gianrossi R, Detrano R, Mulvihill D, Lehmann K, Dubach P, Colombo A et al.Exercise-induced ST depression in the diagnosis of coronary artery disease. A metaanalysis. Circulation 1989 ;80(1):87-98.75. Hoffmann U, Truong QA, Schoenfeld DA, Chou E.T., Woodard P.K., NagurneyJ.T. et al. Coronary CT angiography versus standard evaluation in acute chest pain(ROMICAT-II).N.Engl.J.Med.2012;367:299-308.DOI:10.1016/j.jacc.2011.03.06876. Litt HI, Gatsonis C, Snyder B, Singh H, Miller ChD, Entrikin DW et al. CTangiography for safe discharge of patients with possible acute coronary syndromes.N Engl J Med 2012; 366:1393-1403. DOI: 10.1056/NEJMoa120116377.
Branch KR, Bresnahan BW, Veenstra DL, Shuman WP, Weintraub WS, BuseyJM et al. Economic outcome of cardiac CT- based evaluation and standard of carefor suspected acute coronary syndrome in the emergency department: a decisionanalytic model. Acad. Radiol. 2012;19(3):265-73.DOI:10.1016/j.acra.2011.10.029.78. Hamilton-Craig C, Fifoot A, Hansena M, Pincus M, Chan J, Walters DL et al.Diagnostic performance and cost of CT angiography versus stress ECG — Arandomized prospective study of suspected acute coronary syndrome chest pain inthe emergency department (CT-COMPARE). Int J Cardiol. 2014; 177(3):867-73.DOI:10.1016/j.ijcard.2014.10.09010379.
Hoffmann U, Ferencik M, Udelson JE, Picard MH, Truong QA, Patel MR et al.Prognostic Value of Noninvasive Cardiovascular Testing in Patients with StableChest Pain: Insights from the PROMISE Trial. Circulation. 2017;135(24):23202332. DOI: 10.1161/CIRCULATIONAHA.116.02436080. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation.1995;92:657-671.81. Kern MJ, Meier B. Evaluation of the culprit plaque and the physiologicalsignificance of coronary atherosclerotic narrowings.
Circulation. 2001;103:31423149.82. Mancini GB, Hartigan PM, Bates ER, et al. Angiographic disease progressionand residual risk of cardiovascular events while on optimal medical therapy:observations from the COURAGE Trial. Circ Cardiovasc Interv. 2011;4:545-552.doi: 10.1161/circinterventions.110.96006283. Aroney CN, Dunlevie HL, Bett JH. Use of an accelerated chest pain assessmentprotocol in patients at intermediate risk of adverse cardiac events. Med. J.
Aust.2003; 178 (8): 370-37484. Parsonage WA, Cullen L, Younger JF. The approach to patients with possiblecardiacchest pain. Med. J. Aust. 2013; 199 (1): 30-34. DOI:10.5694/mja12.1117185.Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF,et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a104report of the American College of Cardiology/American Heart Association TaskForce on Practice Guidelines (Committee to Update the 1997 Exercise TestingGuidelines). J Am Coll Cardiol. 2002 ;40(8):1531-40.
Erratum in: J Am CollCardiol. 2006;48(8):1731.86. Gianrossi R, Detrano R, Mulvihill D, Lehmann K, Dubach P, Colombo A et al.Exercise-induced ST depression in the diagnosis of coronary artery disease. A metaanalysis. Circulation 1989 ;80(1):87-98.87. Hoffmann U, Truong QA, Schoenfeld DA, Chou E.T., Woodard P.K., NagurneyJ.T.
et al. Coronary CT angiography versus standard evaluation in acute chest pain(ROMICAT-II).N.Engl.J.Med.2012;367:299-308.DOI:10.1016/j.jacc.2011.03.06888. Litt HI, Gatsonis C, Snyder B, Singh H, Miller ChD, Entrikin DW et al. CTangiography for safe discharge of patients with possible acute coronary syndromes.N Engl J Med 2012; 366:1393-1403. DOI: 10.1056/NEJMoa120116389. Branch KR, Bresnahan BW, Veenstra DL, Shuman WP, Weintraub WS, BuseyJM et al. Economic outcome of cardiac CT- based evaluation and standard of carefor suspected acute coronary syndrome in the emergency department: a decisionanalytic model.
Acad. Radiol. 2012;19(3):265-73.DOI:10.1016/j.acra.2011.10.029.90. Hamilton-Craig C, Fifoot A, Hansena M, Pincus M, Chan J, Walters DL et al.Diagnostic performance and cost of CT angiography versus stress ECG — A105randomized prospective study of suspected acute coronary syndrome chest pain inthe emergency department (CT-COMPARE).
Int J Cardiol. 2014; 177(3):867-73.DOI:10.1016/j.ijcard.2014.10.09091. Hoffmann U, Ferencik M, Udelson JE, Picard MH, Truong QA, Patel MR et al.Prognostic Value of Noninvasive Cardiovascular Testing in Patients with StableChest Pain: Insights from the PROMISE Trial.
Circulation. 2017;135(24):23202332.DOI: 10.1161/CIRCULATIONAHA.116.02436092. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation.1995;92:657-671.93. Kern MJ, Meier B. Evaluation of the culprit plaque and the physiologicalsignificance of coronary atherosclerotic narrowings. Circulation. 2001;103:31423149.94. Mancini GB, Hartigan PM, Bates ER, et al. Angiographic disease progressionand residual risk of cardiovascular events while on optimal medical therapy:observations from the COURAGE Trial. Circ Cardiovasc Interv. 2011;4:545-552.DOI: 10.1161/CIRCINTERVENTIONS.110.96006295. Rodriguez-Granillo G.A., Carrascosa P., Bruining N., Waksman R., GarciaGarcia H.M.
Defining the non-vulnerable and vulnerable patients with computedtomography coronary angiography: evaluation of atherosclerotic plaque burden and106composition. Eur Heart J Cardiovasc Imaging 2016;17:481–491.doi:10.1093/ehjci/jew012.96. Wang J.C., Normand S.L., Mauri L., Kuntz R.E. Coronary artery spatialdistribution of acute myocardial infarction occlusions. Circulation 2004;110:278–284.
doi: 10.1161/01.CIR.0000135468.67850.F497. Voros S., Rinehart S., Qian Z., et al. Coronary atherosclerosis imaging bycoronary CT angiography: current status, correlation with intravascular interrogationandmeta-analysis.JACCCardiovascImaging.2011;4:537–548.doi:10.1016/j.jcmg.2011.03.006.98. Andreini D., Pontone G., Mushtaq S., et al. A long-term prognostic value ofcoronary CT angiography in suspected coronary artery disease.
JACC CardiovascImaging 2012;5:690–701. doi: 10.1016/j.jcmg.2012.03.009.99. Motoyama S., Ito H., Sarai M. Plaque characterization by coronary computedtomography angiography and the likelihood of acute coronary events in mid-termfollow-up. J Am Coll Cardiol 2015;66:337–346. doi: 10.1016/j.jacc.2015.05.069.100. Inoue K., Motoyama S., Sarai M., et al. Serial coronary CT angiographyverified changes in plaque characteristics as an end point: evaluation of effect ofstatinintervention.JACCCardiovascImaging2010;3(7):691-8.doi:10.1016/j.jcmg.2010.04.011.107101. Zeb I., Li D., Nasir K., et al.
Effect of statin treatment on coronary plaqueprogression-aserialcoronaryCTangiographystudy.Atherosclerosis2013;231(2):198-204.doi:10.1016/j.atherosclerosis.2013.08.019.102. Andelius L., Mortensen M.B., Nørgaard B.L., Abdulla J. Impact of statintherapy on coronary plaque burden and composition assessed by coronary computedtomographic angiography: a systematic review and meta-analysis. Eur Heart JCardiovasc Imaging 2018; 0:1-9. doi: 10.1093/ehjci/jey012.103.
Maningat P., Gordon B.R. Breslow J.L. How Do We Improve PatientCompliance and Adherence to Long-Term Statin Therapy? Curr Atheroscler Rep2013;15:291. doi: 10.1007/s11883-012-0291-7.104. Mann D.M., Woodward M., Muntner P., Falzon L., Kronish I. Predictors ofnonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother2010;44(9):1410–21.
doi: 10.1345/aph.1P150.105. Benner J.S., Glynn R.J., Mogun H., et al. Long-term persistence in use of statintherapy in elderly patients. JAMA 2002;288(4):455–61.106. Third Report of the National Cholesterol Education Program (NCEP) ExpertPanel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults(Adult Treatment Panel III) final report. Circulation 2002;106(25):3143–3421.108107. Jackevicius C.A., Mamdani M., Tu J.V. Adherence with statin therapy inelderlypatientswithandwithoutacutecoronarysyndromes.JAMA2002;288(4):462–7.108. Brookhart M.A., Patrick A.R., Schneeweiss S.
et al. Physician follow-up andprovider continuity are associated with long-term medication adherence: a study ofthedynamicsofstatinuse.ArchInternMed2007;167(8):847–52.doi:10.1001/archinte.167.8.847.109. Mann D.M., Woodward M., Muntner P., Falzon L., Kronish I. Predictors ofnonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother2010;44(9):1410–21. doi: 10.1345/aph.1P150.110.
Ma J., Sehgal N.L., Ayanian J.Z., Stafford R.S. National trends in statin use bycoronary heart disease risk category. PLoS Med 2005;2(5):e123. doi:10.1371/journal.pmed.0020123111. Benner J.S., Glynn R.J., Mogun H., et al. Long-term persistence in use of statintherapy in elderly patients. JAMA.
2002;288(4):455–61.112. Newby L.K., La Pointe N.M., Chen A.Y., et al. Long-term adherence toevidence-based secondary prevention therapies in coronary artery disease.Circulation 2006;113(2):203–12. doi: 10.1161/CIRCULATIONAHA.105.505636.109113. Lamberts E.J., Nijpels G., Welschen L.M, et al. Discontinuation of statinsamong patients with type 2 diabetes. Diabetes Metab Res Rev 2012;28(3):241–5.doi: 10.1002/dmrr.1293.114.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
